**Core Concept**
Dexmedetomidine is an alpha-2 adrenergic agonist used for sedation and analgesia. It acts by stimulating alpha-2 adrenergic receptors in the central nervous system, which leads to a decrease in the release of norepinephrine and a subsequent decrease in sympathetic outflow.

**Why the Correct Answer is Right**
The analgesic action of dexmedetomidine is primarily mediated through the activation of alpha-2 adrenergic receptors in the spinal cord and brainstem. This results in a decrease in the release of excitatory neurotransmitters such as substance P and glutamate, and an increase in the release of inhibitory neurotransmitters such as GABA and adenosine. The activation of alpha-2 adrenergic receptors also leads to an increase in the release of endogenous opioids, which contributes to its analgesic action. The specific receptor subtype involved in its analgesic action is the alpha-2A adrenergic receptor.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because dexmedetomidine does not act on muscarinic receptors, which are involved in the parasympathetic nervous system.

**Option B:** This option is incorrect because dexmedetomidine does not act on opioid receptors, which are involved in the analgesic action of opioids such as morphine and fentanyl.

**Option C:** This option is incorrect because dexmedetomidine does not act on N-methyl-D-aspartate (NMDA) receptors, which are involved in the excitatory neurotransmission in the central nervous system.

**Clinical Pearl / High-Yield Fact**
It's worth noting that dexmedetomidine has a unique pharmacological profile that allows it to provide sedation and analgesia without causing significant respiratory depression, making it a useful agent in the intensive care unit.

**Correct Answer: C. alpha-2 adrenergic receptor**